Deciphera Pharmaceuticals Inc (DCPH)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

200 SMITH STREET WALTHAM, MA 02451

Deciphera Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops kinase inhibitor treatments for various type of cancer diseases including gastrointestinal, stromal tumors, advance systemic mastocytosis, gliomas, and other solid tumors. Deciphera Pharmaceuticals serves patients globally.

Data based on most recent fiscal year report
Market Cap3.398 Billion Shares Outstanding51.04 Million Avg Volume577.878 Thousand
1-Yr BETA vs S&P TR1.186 Current Ratio13.24 Quick Ratio13.24
View SEC Filings from DCPH instead.

View recent insider trading info

Funds Holding DCPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DCPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

2.3 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOERTER STEVEN L. PRESIDENT AND CEO

  • Officer
  • Director
41,830 2020-03-18 2

RATCLIFFE LIAM

  • Director
2,800 2020-03-03 0

KELLY THOMAS PATRICK CHIEF FINANCIAL OFFICER

  • Officer
7,040 2020-02-18 10

FLYNN DANIEL LEE CHIEF SCIENTIFIC OFFICER

  • Officer
189,466 2020-02-18 8

SHERMAN MATTHEW L EVP & CHIEF MEDICAL OFFICER

  • Officer
36,760 2020-02-18 3

ALLEN PATRICIA L

  • Director
0 2020-01-24 2

MARTIN DANIEL C. CHIEF COMMERCIAL OFFICER

  • Officer
17,000 2020-01-22 2

KELLEY SUSAN L.

  • Director
0 2020-01-16 2

MORL CHRISTOPHER JOHN CHIEF BUSINESS OFFICER

  • Officer
0 2020-01-15 6

TAYLOR MICHAEL DOUGLAS

  • Director
0 2020-01-02 5

BRISTOL JAMES ARTHUR

  • Director
0 2020-01-02 4

SQUARER RON

  • Director
0 2019-12-04 3

FRIEDMAN FRANKLIN STUART

  • Director
0 2019-11-25 3

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

NEW LEAF VENTURES III, L.P.

NEW LEAF BIOPHARMA OPPORTUNITIES I, L.P.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF BPO ASSOCIATES I, L.P.

  • 10% Owner
7,708,280 2019-08-15 1

ROSS MICHAEL JAY

  • Director
0 2019-06-11 1

WALSH DENNIS LEO

  • Director
0 2019-06-11 1

BENZ EDWARD J. JR

  • Director
0 2019-06-11 1

MARTIN JOHN RICHARD

  • Director
0 2019-06-11 1

RUDDY STEPHEN B. CHIEF TECHNICAL OFFICER

  • Officer
0 2019-01-30 0

BRIGHTSTAR ASSOCIATES LLC

  • 10% Owner
16,572,370 2017-10-02 0

ROSEN OLIVER CHIEF MEDICAL OFFICER

  • Officer
0 2017-10-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-03-19 F 2,164 $39.22 d 42,350 41,830.00 direct yes

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-03-19 F 4,494 $35.78 d 49,756 41,830.00 direct yes

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-03-19 F 4,230 $38.26 d 44,514 41,830.00 direct yes

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-03-19 F 520 $39.98 d 41,830 41,830.00 direct yes

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-03-19 F 1,012 $36.88 d 48,744 41,830.00 direct yes

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-03-18 M 2,250 $25.40 a 54,250 41,830.00 direct

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2020-02-18 A 7,040 a 7,040 7,040.00 direct

FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER

2020-02-18 A 42,190 d 42,190 189,466.00 direct

SHERMAN MATTHEW L - Officer EVP & CHIEF MEDICAL OFFICER

2020-02-18 A 1,760 a 36,760 36,760.00 direct

FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER

2020-02-18 A 7,040 a 98,446 189,466.00 direct

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2020-02-18 A 42,190 d 42,190 7,040.00 direct

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-02-18 A 180,000 a 180,000 0.00 direct

SHERMAN MATTHEW L - Officer EVP & CHIEF MEDICAL OFFICER

2020-02-18 A 10,520 d 10,520 36,760.00 direct

Elevate your investments